Jul. 15 at 2:18 AM
$ENTBF - The company has accumulated 300 K in total debt with debt to equity ratio (D/E) of 0.05, which may suggest the company is not taking enough advantage from borrowing. Entheon Biomedical Corp has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Entheon Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Entheon Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Entheon Biomedical Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Entheon to invest in growth at high rates of return. When we think about… https://www.macroaxis.com/stock-analysis/ENTBF/Entheon-Biomedical-Corp #insidertrading #stocks #fintechnews
